Evidence map›Paper›PMID 35399217›Full record

ArticleToxicology reports2022

Evaluation of the haematinic, antioxidant and anti-atherosclerotic potential of

Silvanus Olu Innih, Ikechi Gerald Eze, Kingsley Omage

Open access · goldAbstract read
In one paragraph

Article in Toxicology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Multidimensional Uses of Bitter Melon (Current organic synthesis · 2025
    Review
  4. Article
  5. Article
  6. Toxicology reports · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Silvanus Olu InnihDepartment of Anatomy, School of Basic Medical Sciences, College of Medical Sciences, University of Benin, Benin City, Nigeria.
Ikechi Gerald EzeDepartment of Anatomy, School of Basic Medical Sciences, College of Medical Sciences, University of Benin, Benin City, Nigeria.
Kingsley OmageDepartment of Biochemistry, College of Basic Medical Sciences, Igbinedion University, Okada, Edo State, Nigeria.
University of Benin · NGIgbinedion University · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Purpose: To evaluate the anti-atherosclerotic potential of Methods: Seventy-two experimental rats were randomly assigned into 9 groups (I-IX) of 8 rats each. Group I (control), was given 1 ml distilled water; II received 250 mg/kg. Results: Glutathione peroxidase (GPx), Malondialdehyde (MDA) and Catalase (CAT) activities were significantly higher in the treated groups as compared to the control groups. There were significant increases in the monocyte counts of the groups given low dose (250 mg/kg) of the extract (LDMC), high dose (500 mg/kg) of the extract (HDMC), as well as atorvastatin. The mean corpuscular volume (MCV) and mean corpuscular haemoglobin (MCH) of the test groups administered were significantly higher than that of the control group. However, only the group administered with cholesterol plus HDMC showed significantly lower mean corpuscular haemoglobin concentration (MCHC) than that of the control group. Histological sections of the aorta show degeneration of the internal elastic lamina in the group fed with the diet only as well as vascular ulceration and stenosis in the aorta and heavy perivascular infiltrates of inflammatory cells. These alterations were however not visible in the groups administered with the extracts, as well as atorvastatin. Conclusion: Our findings show the possible anti-atherosclerotic potential of the extract, which could be compared to that of the standard drug (atorvastatin).

Indexed as

AtherosclerosisAtorvastatinCAT, CatalaseDifferential blood countGPx, Glutathione PeroxidaseHaematocritHCT, HaematocritHDMC, High Dose Momordica charantiaHMG-CoA, Hydroxylmehtylglutharyl Coenzyme ALD, Lethal DoseLDMC, Low Dose Momordica charantiaMCHC, Mean Corpuscular Haemoglobin ConcentrationMCH, Mean Corpuscular HaemoglobinMCV, Mean Corpuscular VolumeMDA, MalondialdehydeMomordica charantiaMPV, Mean Platelet VolumeOxidative stressPCV, Packed Cell VolumePLT, PlateletsPTAH, Phophostungstic Acid HaematoxylinRBC, Red Blood CellROS, Reactive Oxygen SpeciesSOD, Superoxide DismutaseTBA, Thiobarbituric AcidTCA, Trichloroacetic AcidWBC, White Blood Cell

Identifiers

PMID35399217
PMCPMC8987383
OpenAlexW4220740586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.